Literature DB >> 11040015

Complex stenosis morphology and vasomotor responses to inhibition of nitric oxide synthesis.

D Tousoulis1, C Tentolouris, T Crake, G Goumas, C Stefanadis, P Toutouzas, G Davies.   

Abstract

OBJECTIVE: To assess the relation between coronary vasomotor effects of N(G)-monomethyl-L-arginine (LNMMA) administration and coronary stenosis morphology, length, and severity in patients with stable angina.
DESIGN: In 28 patients (24 male, four female) with coronary artery disease and chronic stable angina, intracoronary normal saline and 4 micromol/min LNMMA were infused for four minutes each, followed by an intracoronary bolus of 250 microg glyceryl trinitrate. Coronary stenoses were classified as concentric (smooth), eccentric (smooth), or complicated (irregular). The diameters of these stenoses and their adjacent reference proximal segments were measured by quantitative angiography.
RESULTS: During LNMMA infusion a significantly larger proportion of complicated stenoses than concentric and eccentric stenoses constricted by >/= 5% (p < 0.01) and the magnitude of vasoconstriction was greater in complicated than in concentric and eccentric stenoses (p < 0.05). For complicated stenoses the magnitude of constriction (in mm) with reference to normal saline was greater than that of the concentric and eccentric stenoses (p < 0.05), whereas concentric and eccentric stenoses constricted similarly. Irrespective of the type of morphology, there was a correlation (p < 0.05) between both the severity and the length of stenoses and the magnitude of vasoconstriction to LNMMA. A similar proportion of concentric, eccentric, and complicated stenoses showed >/= 5% increase in diameter with glyceryl trinitrate, and the magnitude of the response was similar in the three groups.
CONCLUSIONS: In patients with coronary artery disease, the response to LNMMA is greater when stenosis morphology is complex, indicating greater nitric oxide activity. This provides further evidence that plaques with complex morphology are in an active state.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11040015      PMCID: PMC1729469          DOI: 10.1136/heart.84.5.529

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  42 in total

1.  Preangioplasty complicated coronary stenosis morphology as a predictor of restenosis.

Authors:  D Tousoulis; J C Kaski; G Davies; W Pereira; H el Tamimi; E McFadden; A Maseri
Journal:  Am Heart J       Date:  1992-01       Impact factor: 4.749

2.  Enhanced vasomotor responses of complex coronary stenoses to acetylcholine in stable angina pectoris.

Authors:  D Tousoulis; T Crake; J C Kaski; S D Rosen; A W Haider; G J Davies
Journal:  Am J Cardiol       Date:  1995-04-01       Impact factor: 2.778

3.  Effects of 5-hydroxytryptamine on capillary and arteriovenous anastomotic blood flow in the human hand and forearm and in the pig hind leg.

Authors:  G Blauw; A H Bom; P van Brummelen; J Camps; J W Arndt; P D Verdouw; P C Chang; P A van Zwieten; P R Saxena
Journal:  J Cardiovasc Pharmacol       Date:  1991-02       Impact factor: 3.105

4.  Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production.

Authors:  Y Ohara; T E Peterson; H S Sayegh; R R Subramanian; J N Wilcox; D G Harrison
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

5.  Coronary vasomotor effects of serotonin in patients with angina. Relation to coronary stenosis morphology.

Authors:  D Tousoulis; G Davies; E McFadden; J Clarke; J C Kaski; A Maseri
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

6.  Rapid angiographic progression of coronary artery disease in patients with angina pectoris. The role of complex stenosis morphology.

Authors:  J C Kaski; M R Chester; L Chen; D Katritsis
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

7.  N-nitro L-arginine causes coronary vasoconstriction and inhibits endothelium-dependent vasodilatation in anaesthetized greyhounds.

Authors:  O L Woodman; G J Dusting
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

8.  Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits.

Authors:  A Mügge; R P Brandes; R H Böger; A Dwenger; S Bode-Böger; S Kienke; J C Frölich; P R Lichtlen
Journal:  J Cardiovasc Pharmacol       Date:  1994-12       Impact factor: 3.105

9.  Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.

Authors:  D C Lefroy; T Crake; N G Uren; G J Davies; A Maseri
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

10.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Authors:  Z S Galis; G K Sukhova; M W Lark; P Libby
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

View more
  2 in total

1.  Vasomotion and nitric oxide bioactivity in diseased coronary arteries.

Authors:  D Tousoulis; G J Davies; T Crake; P C Toutouzas
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

2.  Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque.

Authors:  D Tousoulis; G J Davies; C Tentolouris; G Goumas; C Stefanadis; P Toutouzas
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.